FDA clears Orthofix's limb-lengthening system:
This article was originally published in Clinica
Executive Summary
The US FDA has cleared for sale Orthofix International's internal limb-lengthening device. The ISKD (intramedullary skeletal kinetic distractor) system consists of a telescoping tubular structure that is implanted inside the bone to be lengthened. It uses a magnetic sensor to monitor limb-lengthening progress on a daily basis. Once lengthening is complete, the system stabilises the lengthened bone. Orthofix, of Huntersville, North Carolina, estimates that the market for the ISKD device is worth around $50 million.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.